Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00071539
Recruitment Status : Completed
First Posted : October 29, 2003
Last Update Posted : January 20, 2012
Information provided by (Responsible Party):
Teva Pharmaceutical Industries

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2006
  Actual Study Completion Date : July 2006